Diseases [C] » Nutritional and Metabolic Diseases [C18] » Metabolic Diseases » Glucose Metabolism Disorders » Hyperinsulinism » Insulin Resistance » Metabolic Syndrome
Diseases [C] » Nutritional and Metabolic Diseases [C18] » Metabolic Diseases » Metabolic Syndrome
Description
A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state. MeSH
Hierarchy View
Phase 4 Indicated Drugs (89)
Phase 3 Indicated Drugs (31)
Phase 2 Indicated Drugs (47)
Phase 1 Indicated Drugs (12)
Other Experimental Indicated Drugs (121)
Organization Involved with Phase 4 Indications (124)
Atlanta Heart Specialists, LLC
Birjand University of Medical Sciences
Boryung Pharmaceutical Company
Brain & Behavior Research Foundation
Case Western Reserve University
Chinese University of Hong Kong
Gottfried Wilhelm Leibniz Universität Hannover
Hospital Italiano de Buenos Aires
Instituto de Salud de Bucaramanga
Instituto Mexicano del Seguro Social
Katholieke Universiteit Leuven
Los Angeles Biomedical Research Institute
National Center for Research Resources (NCRR)
National Heart Foundation, Australia
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Mental Health (NIMH)
National Institutes of Health (NIH)
The University of Texas, Dallas
Ukrainian Medical Stomatological Academy
University of California, San Diego
University of Naples Frederico II
University of Roma La Sapienza
University of Science Malaysia
University of Southern Denmark
University of Texas, Galveston
University of Western Australia
Veterans Medical Research Foundation
Virginia Commonwealth University
Volgograd State Medical University
Organization Involved with Phase 3 Indications (73)
Bambino Gesù Hospital and Research Institute
British Columbia Cancer Agency
Canadian Institutes of Health Research (CIHR)
Canadian Urologic Oncology Group
Heart and Stroke Foundation of Canada
Institute Of Cardiology & Internal Diseases, Kazakhstan
Isala Clinics, Zwolle, The Netherlands
Medical Research Foundation, The Netherlands
National Nutrition and Food Technology Institute
Prostate Cancer Canada Network
Russian Academy of Medical Sciences
St. Elizabeth's Medical Center of Boston
Taichung Veterans General Hospital
Technical University of Dresden
Translational Research Institute for Metabolism and Diabetes, Florida
Universidad Autonoma de Nuevo Leon
Organization Involved with Phase 2 Indications (90)
Badalona Hospital Germans Trias i Pujol
Beilinson Hospital, Petach Tikva
Cameroon Nutritional Science Society
German Federal Ministry of Education and Research
Holy Family Hospital, Nazareth, Israel
Instituto Nacional de Cardiologia Ignacio Chavez
Laboratorios Silanes S.A. de C.V.
Moorgreen Hospital, Southampton
National Center for Complementary and Integrative Health (NCCIH)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Neurological Disorders and Stroke (NINDS)
Republican Scientific Center for Emergency Medicine
The Craig H. Neilsen Foundation
The Weston A. Price Foundation
Torrent Pharmaceuticals Limited
United States Department of Agriculture
Organization Involved with Phase 1 Indications (12)
Organization Involved with Other Experimental Indications (164)
Agriculture and Agri-Food Canada
Alliance for Potato Research and Education
Aristotle University of Thessaloniki
Atlanta Vascular Research Foundation
Canadian Collaborative Research Network
Central Hospital of Kanta-Hame
Central Institute of Psychiatry, Ranchi, India
Centre for Fetal Programming, Denmark
Danish Council for Independent Research
Federal University of Rio de Janeiro
Federal University of Rio Grande do Sul
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
German Diabetes Foundation, Munich, Germany
German Institute of Human Nutrition
Icahn School of Medicine at Mount Sinai
Illinois Institute of Technology
Institute of Home Economics, India
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Klinikum Ernst von Bergmann Augenklinik Laserzentrum
Les Derives Resiniques et Terpeniques
Liverpool John Moores University
National Cancer Institute (NCI)
National Institute on Aging (NIA)
Norwegian University of Life Sciences
Oregon Health and Science University
Pennington Biomedical Research Center
Pontificia Universidad Catolica de Chile
Rio de Janeiro State University
Swiss Federal Institute of Technology
The Danish Council for Strategic Research
Top Institute Food and Nutrition
Université catholique de Louvain
University of Alabama, Birmingham
University of California, Davis
University of Nevada, Las Vegas
U.S. Highbush Blueberry Council
VTT Technical Research Centre, Finland
Washington State Fruit Commission
ZonMw: The Netherlands Organisation for Health Research and Development
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
